Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208
2013
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
187
Citations
NaN
KQI